Friday, December 15th | 27 Kislev 5778

Close

Be in the know!

Get our exclusive daily news briefing.

Subscribe
February 17, 2016 2:43 pm

‘Potentially Revolutionary’ Leukemia Treatment Based on Israeli Research Revealed

avatar by JNS.org

Email a copy of "‘Potentially Revolutionary’ Leukemia Treatment Based on Israeli Research Revealed" to a friend
A healthy human T-cell. The research first pioneered by a Weizmann Institute Israeli scientist shows that T-cells can be modified genetically to destroy leukemia tumor cells. Photo: NIAID/NIH via Wikimedia Commons.

A healthy human T-cell. The research first pioneered by a Weizmann Institute Israeli scientist shows that T-cells can be modified genetically to destroy leukemia tumor cells. Photo: NIAID/NIH via Wikimedia Commons.

JNS.org –  A cancer study showing results hailed this week as potentially revolutionary for the treatment for leukemia is based on research undertaken by Weizmann Institute Prof. Zelig Eshhar.

An article in the journal Science Translational Medicine outlines how researchers from the University of Pennsylvania’s Abramson Cancer Center and the Perelman School of Medicine found that 27 out of 29 advanced leukemia patients either went into remission, or saw their illness go away completely after their T-cells were modified genetically, a success rate of nearly 94 percent. In the study carried out at the Fred Hutchinson Cancer Research Center in Seattle, Wa. the cells were equipped with synthetic molecules the were able to destroy the tumor cells, particularly in cases of acute lymphoblastic leukemia (ALL).

These results are not surprising for Prof. Eshhar, who pioneered the idea with a 1989 study published in the Proceedings of the National Academy of Sciences, in which he replaced the T cell’s natural receptor with one of his choice, showing that T-cells can be engineered to attach to any entity. Eshhar won the Jewish state’s prestigious Israel Prize for his research in 2015.

“I’m not surprised to hear about the results,” he said, the Times of Israel reported. “In our lab, we cured many rats and mice of cancer. I have been saying for years that we could do this in people, as well.”

Related coverage

December 14, 2017 11:43 am
0

Family of Mumbai Terror Victims Granted State-Owned Home in Israel

JNS.org - Rabbi Nachman and Freida Holtzberg, who lost their son and daughter-in-law in the 2008 terror attack on the Indian...

“I felt a great sense of satisfaction upon hearing the news,” added Eshhar. “The next task of my lab and others working on this is to expand it and try to attack other forms of cancer.”

He cautioned, however, that more work is needed before the treatment could really be seen as a cancer cure.

“Obviously much more work is needed,” he said. “One issue with this kind of therapy is that you have to develop specific T-cells for each kind of cancer. But studies like those are a great impetus to move forward with research. I believe the day will come when we will see many more cancers treated in this manner.”

Share this Story: Share On Facebook Share On Twitter Email This Article

Let your voice be heard!

Join the Algemeiner
  • Bob Webb

    Any clinical trials being scheduled in the U.S.?

  • Mickey Oberman

    Will the media give credit where credit is due?

    Not if it can avoid mentioning Jews in a vavourable light.

  • Another wonderful breakthrough for a a cure with 94% success, this is unheard off. Way to go to Israel for your humanitarian contribution!!!

  • I was treated ten years ago for CLL. Is renewel a potential possibility ?. I lead a clean life style in S. W. Utah witH little anxioty I am a 81 years old widower, swim or kayak almost daily in spring, summer and fall>

  • Deavman

    I strongly suggest to the unfatiguable BDS activists to hurry and picket all major hospitals in the West to make sure that they won’t use this zionist invention and thus keep the world safe from the Jewish colonialism.

  • Ike

    Great achievement.

  • Yes, someday more cancers will be treated by T-cell modifications, and many lives saved. Kol ha-kavod to Professor Eshhar and his team!

  • Tal

    Good. Now don’t share it. The rest of the world can go to hell.

Algemeiner.com